Senior Director, Launch Excellence
CG Oncology
About this role
A Senior Director, Launch Excellence at CG Oncology leads integrated launch planning and execution, serving as the central orchestrator across all functions to ensure full organizational readiness for Day 1 and beyond. The role owns the integrated U.S. launch plan for cretostimogene, aligning multiple departments into a cohesive execution model.
Skills
Qualifications
About CG Oncology
cgoncology.comCG Oncology is a late-stage biopharmaceutical company focused on developing bladder‑sparing immunotherapies for bladder cancer. The company specializes in oncolytic immunotherapy and is advancing cretostimogene grenadenorepvec as a lead therapeutic candidate. CG Oncology’s programs aim to provide non-surgical, targeted treatment options that preserve the bladder and improve outcomes for patients with bladder cancer. They emphasize clinical development and commercialization readiness to bring these innovative therapies to market.
About CG Oncology
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for CG Oncology.
Salary
$250k – $265k
per year